Galecto, Inc. (GLTO) Financial Statements (2025 and earlier)

Company Profile

Business Address 75 STATE STREET
BOSTON, MA 02109
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) (USD)

3/31/2025
MRQ
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments14,175,00033,151,00060,224,000100,191,000163,582,000
Cash and cash equivalent14,175,00021,465,00032,786,00062,563,000163,582,000
Short-term investments  11,686,00027,438,00037,628,000 
Receivables45,000280,000587,000598,000401,000
Prepaid expense680,000859,000857,0002,062,0001,884,000
Other undisclosed current assets1,939,0002,484,0002,242,0007,251,0003,428,000
Total current assets:16,839,00036,774,00063,910,000110,102,000169,295,000
Noncurrent Assets
Operating lease, right-of-use asset73,000247,000810,000834,000885,000
Property, plant and equipment57,00078,000357,000203,000 
Long-term investments and receivables   5,832,0009,048,000 
Long-term investments   5,832,0009,048,000 
Restricted cash and investments     254,000
Other noncurrent assets163,0001,128,0002,279,0002,028,0001,162,000
Total noncurrent assets:293,0001,453,0009,278,00012,113,0002,301,000
TOTAL ASSETS:17,132,00038,227,00073,188,000122,215,000171,596,000
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities1,197,0005,830,00011,107,0004,544,0005,566,000
Accounts payable377,0001,702,0003,350,0001,531,0002,851,000
Accrued liabilities820,0004,128,0007,757,0003,013,0002,715,000
Total current liabilities:1,197,0005,830,00011,107,0004,544,0005,566,000
Noncurrent Liabilities
Long-term debt and lease obligation:    448,000541,000
Liabilities, other than long-term debt104,00066,000328,000  
Other liabilities43,000    
Operating lease, liability61,00066,000328,000448,000541,000
Other undisclosed noncurrent liabilities    (448,000)(541,000)
Total noncurrent liabilities:104,00066,000328,000448,000541,000
Total liabilities:1,301,0005,896,00011,435,0004,992,0006,107,000
Temporary equity, including noncontrolling interest1,360,000    
Equity
Equity, attributable to parent, including:15,831,00032,331,00061,753,000117,223,000165,489,000
Additional paid in capital291,898,000288,036,000279,733,000273,655,000269,175,000
Accumulated other comprehensive income (loss)97,000380,000(244,000)(320,000)674,000
Accumulated deficit(277,524,000)(256,085,000)(217,736,000)(156,112,000)(104,360,000)
Other undisclosed equity, attributable to parent1,360,000    
Other undisclosed equity(1,360,000)    
Total equity:14,471,00032,331,00061,753,000117,223,000165,489,000
TOTAL LIABILITIES AND EQUITY:17,132,00038,227,00073,188,000122,215,000171,596,000

Income Statement (P&L) (USD)

3/31/2025
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating expenses(22,260,000)(39,905,000)(61,207,000)(52,227,000)(33,637,000)
Other undisclosed operating income     67,274,000
Operating income (loss):(22,260,000)(39,905,000)(61,207,000)(52,227,000)33,637,000
Nonoperating income (expense)862,0001,556,000(417,000)475,000(1,200,000)
Gain (loss), foreign currency transaction, before tax18,000(197,000)(1,069,000)319,000(1,200,000)
Income (loss) from continuing operations before equity method investments, income taxes:(21,398,000)(38,349,000)(61,624,000)(51,752,000)32,437,000
Other undisclosed loss from continuing operations before income taxes     (67,274,000)
Loss from continuing operations before income taxes:(21,398,000)(38,349,000)(61,624,000)(51,752,000)(34,837,000)
Income tax expense(41,000)    
Loss from continuing operations:(21,439,000)(38,349,000)(61,624,000)(51,752,000)(34,837,000)
Loss before gain (loss) on sale of properties:(51,752,000)(34,837,000)
Other undisclosed net income     
Net loss:(21,439,000)(38,349,000)(61,624,000)(51,752,000)(34,837,000)
Other undisclosed net loss attributable to parent     
Net loss available to common stockholders, diluted:(21,439,000)(38,349,000)(61,624,000)(51,752,000)(34,837,000)

Comprehensive Income (USD)

3/31/2025
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Net loss:(21,439,000)(38,349,000)(61,624,000)(51,752,000)(34,837,000)
Other comprehensive income (loss)(283,000)624,00076,000  
Comprehensive loss:(21,722,000)(37,725,000)(61,548,000)(51,752,000)(34,837,000)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent   (994,000)3,125,000
Comprehensive loss, net of tax, attributable to parent:(21,722,000)(37,725,000)(61,548,000)(52,746,000)(31,712,000)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: